Cuu Long Pharmaceutical Stock price

Equities

DCL

VN000000DCL1

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 07:00:00 2024-03-26 pm EDT 5-day change 1st Jan Change
24,100 VND 0.00% Intraday chart for Cuu Long Pharmaceutical -0.41% -3.60%
Sales 2021 704B 28.85M Sales 2022 1,016B 41.64M Capitalization 1,790B 73.37M
Net income 2021 85.96B 3.52M Net income 2022 112B 4.58M EV / Sales 2021 3.56 x
Net Debt 2021 166B 6.82M Net Debt 2022 352B 14.43M EV / Sales 2022 2.11 x
P/E ratio 2021
26.6 x
P/E ratio 2022
15.4 x
Employees 930
Yield 2021 *
-
Yield 2022
-
Free-Float 41.95%
More Fundamentals * Assessed data
Dynamic Chart
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Cuu Long Pharmaceutical Joint Stock Company Announces Change in Personnel CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Cuu Long Pharmaceutical Joint Stock Company Announces the Resignation of Nghiem Xuan Truong as CFO CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Luong Trong Hai as Director CI
Cuu Long Pharmaceutical Joint Stock Company Announces CEO Changes CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Cuu Long Pharmaceutical Joint Stock Company Provides Earnings Guidance for the Fiscal Year 2022 CI
Cuu Long Pharmaceutical Joint Stock Company Announces Resignation of Nguyen Ngoc Vinh as Deputy CEO CI
Cuu Long Pharmaceutical Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
1 week-0.41%
Current month-2.03%
1 month-1.83%
3 months-2.82%
6 months+5.47%
Current year-3.60%
More quotes
1 week
24 000.00
Extreme 24000
25 500.00
1 month
24 000.00
Extreme 24000
25 500.00
Current year
23 200.00
Extreme 23200
26 000.00
1 year
21 700.00
Extreme 21700
26 000.00
3 years
21 700.00
Extreme 21700
53 600.00
5 years
16 000.00
Extreme 16000
53 600.00
10 years
7 428.57
Extreme 7428.5714
53 600.00
More quotes
Managers TitleAgeSince
Chief Executive Officer - 21-05-17
Chairman 48 14-12-18
Director of Finance/CFO - -
Members of the board TitleAgeSince
Director/Board Member 53 -
Chairman 48 14-12-18
Director/Board Member - -
More insiders
Date Price Change Volume
24-03-27 24,100 0.00% 14,200
24-03-26 24,100 0.00% 11,900
24-03-25 24,100 -0.62% 30,600
24-03-22 24,250 -0.41% 97,000
24-03-21 24,350 +0.62% 59,400

End-of-day quote Ho Chi Minh S.E., March 26, 2024

More quotes
Cuu Long Pharmaceutical Joint Stock Corporation (Pharimexco) is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, markets and distributes pharmaceutical drugs and capsules, as well as medical equipment and supplies. It is also involved in the manufacture and trading of functional food, cosmetic products, chemicals and other materials for pharmaceutical production. Other activities include the manufacture of specialized packagings for drugs and medical products, as well as the cultivation of traditional herbs.
More about the company
  1. Stock
  2. Equities
  3. Stock Cuu Long Pharmaceutical - Ho Chi Minh S.E.